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Background. The limited availability of microbiology services in sub-Saharan Africa impedes accurate diagnosis of bacterial 
pathogens and understanding of trends in prevalence and antibiotic sensitivities. We aimed to characterize bacteremia among hos-
pitalized children in The Gambia and to identify factors associated with bacteremia and mortality.
Methods. We prospectively studied children presenting with suspected severe infection to 2 urban hospitals in The Gambia, be-
tween January 2013 and September 2015. Demographic and anthropometric data, clinical features, management, and blood culture 
results were documented. Urine screens for antibiotic activity were performed in a subset of participants.
Results. Of 411 children enrolled (median age, 29 months; interquartile range, 11–82), 79.5% (325 of 409) reported prehos-
pital antibiotic use. Antimicrobial activity by urinary screen for antibiotic activity was detected in 70.8% (n = 80 of 113). Sixty-six 
bacterial pathogens were identified in 65 (15.8%) participants and Staphylococcus aureus predominated. Gram-positive organisms 
were more commonly identified than Gram-negative (P < .01). Antibiotic resistance against first-line antimicrobials (ampicillin and 
gentamicin) was common among Gram-negative bacteria (39%; range, 25%–100%). Factors significantly associated with bacteremia 
included the following: gender, hydration status, musculoskeletal examination findings, admission to the Medical Research Council 
The Gambia at London School of Hygiene & Tropical Medicine hospital, and meeting sepsis criteria. Those associated with increased 
mortality were presence of a comorbidity, clinical pallor, tachypnea, and altered consciousness. Tachycardia was associated with re-
duced mortality.
Conclusions. The bacteremia rate in children with suspected childhood life-threatening infectious diseases in The Gambia 
is high. The pattern of pathogen prevalence and antimicrobial resistance has changed over time compared with previous studies 
illustrating the importance of robust bacterial surveillance programs in resource-limited settings.
Keywords. antibiotic; bacteremia; children; Gambia; mortality.
Child mortality in sub-Saharan Africa (SSA) is high, and 
the majority of these deaths can be attributed to bacterial 
infections [1–3]. Passive surveillance systems to monitor 
bacterial infections and associated resistance patterns are 
not common practice [4], and there are few robust estimates 
of the burden of bacteremia in children in resource-limited 
settings [5] due to limited access to microbiology facilities 
and molecular diagnostic tools [6]. In addition, uncon-
trolled (prehospital) use of antibiotics in SSA [7] limits reli-
able identification of bacteria via traditional blood culture. 
This results in a paucity of reliable data on the prevalence 
and sensitivity pattern of commonly isolated pathogens over 
time [2, 8, 9]. Differences in the etiology of pediatric bac-
terial infections between different geographic regions addi-
tionally reduce the efficacy of treatment recommendations 
and immunization programs in SSA [10–15].
A systematic review in 2010 on community-acquired bac-
teremia in Africa, which included a study from The Gambia 
[16], found that Streptococcus pneumoniae and Haemophilus 
influenzae were the most common pathogens in the pediatric 
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population. Although predictors of bacteremia have been 
widely studied in high-income countries [17], these findings 
cannot be translated to the SSA setting because of epidemio-
logical differences. Studies on predictors of pediatric bacte-
remia in SSA are limited. A publication from South Africa [18] 
identified malnutrition to be more common in bacteremic pa-
tients, whereas another from Nigeria [19] highlighted 2 other 
predictors: age less than 6  months and leukocytosis (>15  000 
cells/µL). Pulmonary crackles and leukocytosis (>15 000 cells/
µL) were risk factors identified in Uganda [20]. Another study 
did not identify predictors [21]. There are no recent published 
data on pediatric bacteremia from The Gambia. The last study, 
which was completed more than 10 years ago and combining all 
age groups, showed that patients with leukocytosis were more 
likely to be bacteremic [22].
Studies of community onset sepsis and blood stream infec-
tions in SSA in children outside the neonatal period have shown 
case-fatality rates ranging from 5.2% to 16.6% [9, 13, 18, 23] in 
children with bacteremia and significant levels of sequelae; one 
study in West African children under 5 years old reported dis-
ability at discharge in 13.2% with confirmed bacteremia [13].
In this study, we investigated the prevalence of bacteremia 
and describe antibiotic resistance patterns in children with 
sepsis and severe focal infection (SFI) and the factors associated 
with bacteremia and mortality.
MATERIALS AND METHODS
From January 2013 to September 2015, we conducted a pro-
spective, observational study recruiting children presenting 
with suspected sepsis or SFI to 2 hospitals in urban Gambia. 
This study was nested within the European Union Childhood 
Life-threatening Infectious Disease Study ([EUCLIDS] www.
euclids-project.eu). The European cohort has been described 
previously [24].
Study Participants
Study participants were aged 1 month to less than 18 years with 
suspected sepsis or SFI, who warranted admission for effec-
tive antibiotic treatment. Recruitment was not comprehensive 
and was limited to working hours by the availability of the re-
search team. Patients referred to the tertiary hospital were not 
recruited if they were already on intravenous antibiotics or had 
negative blood cultures at screening.
Definition of Terms
Sepsis was defined as suspected infection plus systemic inflam-
matory response syndrome, as per clinical criteria established by 
international consensus definition [25]. Children not meeting 
sepsis criteria but with a clinical focus of significant infection 
were defined as having SFI with a matching syndrome recorded 
according to the predefined case definitions in the EUCLIDS 
clinical protocol [24]. In cases wherein limitations arose due to 
lack of diagnostic investigations, clinical syndromes were de-
fined using criteria detailed in the World Health Organization 
(WHO) Pocket Book of Hospital Care for Children [26]. 
Anthropometry was categorized according to standard WHO 
criteria [27]. Sequelae at discharge were recorded.
Patient Recruitment
Patients were recruited from 2 hospital settings: the Medical 
Research Council The Gambia at London School of Hygiene 
& Tropical Medicine (MRCG at LSHTM) clinical services hos-
pital and the Edward Francis Small Teaching Hospital (EFSTH). 
Case report forms captured data on sociodemographic details, 
anthropometry, medical history, clinical features, management, 
and results of blood culture and antibiotic sensitivity profiles. 
Data were subsequently transferred to an online, secure study 
database.
The MRCG at LSHTM, located in the greater Banjul area, 
runs a 42-bed inpatient unit providing both pediatric and 
general medical care for staff, the general public, and partici-
pants in MRCG at LSHTM-led clinical research studies. It is 
supported by Good Clinical Laboratory Practice (GCLP) and 
International Organization for Standardization (ISO) 15189 ac-
credited clinical laboratories, ultrasound, and x-ray facilities. 
There is no emergency department, and it does not receive re-
ferrals from other secondary institutions. The medical team 
comprised 2 consultants and 3 full-time medical officers, with 
support from clinical research fellows.
The EFSTH, located in Banjul, is the national teaching hos-
pital receiving admissions from its Emergency Department 
and referrals from other hospitals serving the whole country. 
During the study, the pediatric unit had 73 beds and a medical 
team of 5 pediatric consultants and 10 junior medical staff. It 
has access to laboratory services offering full blood count anal-
ysis, blood grouping, and blood film microscopy for malaria 
parasites. Routine blood culture facilities were not consistently 
available onsite during the study, and blood cultures for study 
patients were processed at the MRCG at LSHTM site. The pedi-
atric unit has an emergency department and offers 24-hour care 
supported by a radiology department with x-ray, ultrasound, 
and computer tomography scan facilities.
Laboratory Methods
Blood Cultures
Blood samples, 1–3 mL, were collected into BD BACTEC PEDS 
PLUS/F culture vials for children aged up to 15 years, and into 
BD BACTEC Plus Aerobic/F* and Plus Anaerobic/F* culture 
bottles for those aged >15 years, by direct inoculation following 
manufacturer’s instructions. Children with suspected endo-
carditis had 3 sets of cultures taken. To ensure uniformity and 
prevention of contamination, collection followed a standard 
protocol where possible. Inoculated blood culture bottles were 
processed at the MRCG at LSHTM microbiology laboratory, 
D
ow
nloaded from
 https://academ
ic.oup.com
/ofid/article-abstract/6/9/ofz332/5539868 by Erasm
us U
niversity R
otterdam
 user on 30 O
ctober 2019
Bacteremia in West Africa • ofid • 3
optimally within 4 hours of collection; however, for a minority 
of blood samples collected out of hours at EFSTH, the sam-
ples were prestored in an incubator for up to 12 hours before 
transfer to the microbiology laboratories. Bacterial isolates were 
obtained using an automated blood-culture system BACTEC 
9050 (Becton Dickinson, Temse, Belgium). In addition, blood 
culture vials were subcultured on agar plates before loading into 
the BACTEC machine, to minimize the risk of losing fastidious 
organisms.
Microbiological procedures were performed using standard 
media if bottles gave a positive signal within 5 days, otherwise 
they were reported negative. Further identification was done 
by cultural morphology, Gram’s staining, biochemical testing, 
and serological agglutination. Staphylococcus isolates were iden-
tified by coagulase, mannitol fermentation, and catalase tests. 
Nontyphoidal Salmonella and other Gram-negatives were iden-
tified using bioMérieux analytical profile index API 20 E (Becton 
Dickinson, Sparks, MD) and serotyped as previously described 
[28]. Antibiotic susceptibility was assessed using disc diffusion 
methods and interpreted according to Clinical and Laboratory 
Standards Institute (CLSI) interpretation guide for the years 
2013 to 2015 [29]. For this study, all organisms found as normal 
skin or oral flora that were found only once were considered to 
be contaminants, including coagulase-negative staphylococci, 
alpha-hemolytic streptococci (other than S pneumoniae), and 
diphtheroids.
Urine Screen for Antibiotic Activity
Urine was collected from a subset of participants (those in 
whom clean-catch sampling was successful) before in-hospital 
antibiotic administration to assess frequency of prehospital an-
tibiotic use. Antibiotic detection were performed according to 
standard methods [30]. Sterile filter paper discs coated with 
20 μL of urine were placed on a Mueller-Hinton agar plate in-
oculated with antibiotic-sensitive Staphylococcus aureus (ATCC 
25923 strain). After 18- to 24-hour incubation at 35–37°C, 
growth inhibition around the disc was considered evidence of 
antibiotic exposure. Commercial antibiotic susceptibility disks 
(penicillin, gentamicin, trimethoprim/sulfamethoxazole, and 
chloramphenicol) were used as positive controls, and sterile sa-
line was used as negative control.
Management of Patients
All patients were managed by pediatricians according to The 
Gambia National Standard Treatment Guideline and WHO 
Pocket Book of Hospital Care for Children [26]. Screening for 
malaria was done on admission with thick-film microscopy 
and treatment offered when confirmed. Standard first-line 
antimicrobials used in The Gambia for treatment of suspected 
sepsis in children are ampicillin or crystalline penicillin, plus 
gentamicin. For patients failing to respond to first-line antibi-
otic therapy, chloramphenicol is the usual antibiotic of choice 
and, where appropriate, ciprofloxacin. Ceftriaxone is usually re-
served for severe sepsis.
Statistical Analysis
Mean (standard deviation) was calculated for normally dis-
tributed variables and median (interquartile range [IQR]) for 
non-parametric variables. Cohen’s kappa coefficient was used to 
measure agreement between reported antibiotic use and urine 
antimicrobial activity. Fisher’s exact tests and χ 2 tests were used 
to compare categorical variables. Univariable binary logistic re-
gression was used to determine the factors associated with bac-
teremia and mortality; intercepts were allowed for odds ratio 
(OR) calculations. When applying a multivariate logistic regres-
sion approach to bacteremia and mortality, a causal diagram was 
drawn before model building in both cases. To identify the most 
significant variables, initial models were built using all clinical 
variables, followed by a variable selection approach in which 
variables with the largest P values were iteratively excluded one 
at a time, until a handful of variables remained, and we have 
shown in Table 2 those with P < .05. Age and sex were retained 
because these were biologically known to affect the predictors 
as well as site of hospital of care. Prehospital antibiotic use was 
retained in the bacteremia model. Statistical calculations were 
performed in Genstat and R.
Ethical Approval
Approval for the EUCLIDS study was obtained from the Joint 
MRCG at LSHTM-Gambia Government Ethics Committee 
(SCC 1287). A  parent/guardian provided written (signed or 
thumb-printed) informed consent for their child to take part in 
the study. For parents not literate in English, an impartial wit-
ness was present throughout the informed consent discussion, 
undertaken in one of the local languages, and the impartial 
witness signed to attest to the completeness of the information 
given.
RESULTS
Patient Characteristics, Bacteremia Prevalence, and Urinary Screen for 
Antibiotic Activity
A total of 411 study participants were recruited, 57.6% (n = 237 
of 411) at the EFSTH. Overall, 60.1% (n = 247 of 411) were male 
with a median age of 29 months (IQR, 11–82). A total of 74.9% 
(n = 308 of 411) reported up-to-date immunizations. Forty-two 
(13.3%) had a history of consanguinity, and 37 (9.0%) had a 
history of a comorbidity including sickle cell disease, cerebral 
palsy, asthma, congenital hydrocephalus, insulin dependent 
diabetes mellitus, epilepsy, and congenital and acquired heart 
diseases. A total of 12.2% (n = 50 of 411) had cigarette smoke 
exposure at home. A total of 3.4% (n = 14 of 411) had confirmed 
malaria infection. A total of 15.5% (n = 54 of 349) had severe 
wasting. A total of 30.2% (n = 124 of 411) were admitted at an-
other healthcare facility before being seen at the study sites. The 
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median duration of symptoms before presentation was 3.9 days 
(IQR, 2.64–7.18), and the median duration of stay at the study 
sites on admission was 6.5 days (IQR, 2.96–11.33).
Sixty-six bacterial pathogens were identified by blood culture 
from 65 of 411 (15.8%) study subjects, including 1 polymicrobial 
blood culture (Escherichia coli and S pneumoniae). Gram-
positive organisms were more commonly identified than 
Gram-negative organisms (9.2% versus 6.8%; P  ≤  .01). The 
most common isolated pathogen was S aureus (22, 5%), which 
was predominantly responsible for soft tissue and/or bone in-
fections with or without sepsis. Table 1 summarizes the blood 
culture findings. Contaminants were present in 5.8% (n = 24 of 
411). The clinical features of patients with and without bacte-
remia are shown in Supplementary Table S1.
Overall, 79.5% (n = 325 of 409)  reported use of antibiotics 
in the 7  days before recruitment. Urine screens for antibiotic 
activity were completed on a subset of 113 recruits, 73 (64.6%) 
of whom reported prehospital antibiotic use in preceding 
3 days; 80 (70.8%) had a positive screen for antibiotic activity 
(Supplementary Table S2). There was moderate agreement be-
tween reported history of antibiotic use and a positive screen 
for antibiotic activity (kappa 0.47). The 113 patients screened 
did not differ significantly in age from the overall cohort (32 vs 
29 months; P = .32). A positive blood culture was found in 16 
of 113 (14.2%) participants in whom the screen was performed. 
There was a trend towards increased bacteremia in patients 
with a positive urine antibiotic screen (OR = 2.9), but this was 
nonsignificant (P = .2; Fisher exact test).
Antimicrobial Resistance
Antibiotic resistance was uncommon among the Gram-positive 
pathogens for commonly used first-line (7.9% [n  =  3 of  38]; 
range, 7%–9%) and second-line (5.3% [n  =  2 of  38]; range, 
0%–14%) antimicrobials. Two cases of Staphylococcus and 1 case 
of S pneumoniae showed resistance to first-line antimicrobials. 
Table 2. Multivariable Analysis for Factors Associated With Bacteremia 
and Mortalitya
Variable Odds Ratio (95% CI) P Value
Analysis for Bacteremia
Male gender 0.37 (0.18–0.77) .01
Admission to MRCG at LSHTM hospital 2.73 (1.28–5.82) .01
Normal hydration status 0.31 (0.12–0.83) .02
Normal musculoskeletal exam 0.13 (0.05–0.32) <.01
Sepsis 12.75 (4.96–32.77) <.01
Analysis for Mortality
History of a comorbidity 3.66 (1.26–10.61) .02
Clinical pallor 4.56 (1.45–14.40) .01
Tachycardia for age 0.39 (0.18–0.84) .02
Tachypnea for age 2.93 (1.22–7.01) .02
Altered consciousness 7.15 (3.21–15.93) <.01
Abbreviations: CI, confidence interval; MRCG at LSHTM, Medical Research Council The 
Gambia at London School of Hygiene & Tropical Medicine; OR, odds ratio.
aClinical parameters were assessed on admission at the time of diagnosis. Top performing 
correlates of bacteremia and mortality were derived using a multivariate logistic regression 
approach, followed by a variable selection approach in which variables with the largest P values 
were iteratively excluded one at a time. The table includes those with those with P < .05.
Table 1. Blood Culture Isolates Stratified by Diagnostic Categorizationa
Blood Culture Isolate
bDiagnostic Categorization
Stratified Prevalence (%)
Blood Culture Isolate
Total (Column %) Sepsis Pneumonia Meningitis Soft Tissue Bone Other Malaria Coinfection
N = 411 N = 202 N = 144 N = 92 N = 43 N = 27 N = 30 N = 14
Staphylococcus aureus 22 (5.4) 17 (77.3) 2 (9.1) 2 (9.1) 8 (36.4) 4 (18.2) 2 (9.1) 0
Streptococcus pneumoniae 14 (3.4) 12 (85.7) 9 (64.3) 3 (21.4) 1 (7.1) 0 (0) 0 (0) 0
Other Gram positives 2 (0.5) 1 (50.0) 0 (0) 0 (0) 1 (50.0) 1 (50.0) 0 (0) 0
Sub-total: Gram-positive 38 (9.2) 30 (78.9) 11 (28.9) 5 (13.2) 10 (26.3) 5 (13.2) 2 (5.3) 0
Neisseria meningitidis 4 (1.0) 2 (50.0) 0 (0) 4 (100.0) 0 (0) 0 (0) 0 (0) 0
Haemophilus influenzaec 6 (1.5) 5 (83.3) 2 (33.3) 3 (50.0) 0 (0) 1 (16.7) 0 (0) 0
Escherichia coli 4 (1.0) 3 (75.0) 2 (50.0) 0 (0) 0 (0) 0 (0) 0 (0) 0
Pseudomonas spp 3 (0.7) 2 (66.7) 1 (33.3) 0 (0) 0 (0) 0 (0) 0 (0) 0
Salmonella sppd 3 (0.7) 1 (33.3) 1 (33.3) 0 (0) 0 (0) 0 (0) 1 (33.3) 0
Other Gram negative 8 (1.9) 7 (87.5) 3 (37.5) 0 (0) 1 (12.5) 0 (0) 0 (0) 1
Sub-total: Gram-negatives 28 (6.8) 20 (71.4) 9 (32.1) 7 (25.0) 1 (3.6) 1 (3.6) 1 (3.6) 1
Total isolates 66 (16.1) 50 (75.8) 20 (30.3) 12 (18.2) 11 (16.7) 6 (9.1) 2 (3.0) 1
aThe numbers of patients with blood culture-confirmed infection with common organisms, broken down into the common clinical syndrome groupings. Apart from the first (Total) column, 
percentages in brackets pertain to the proportion in that row, and may not add up to 100.0 because patients may have more than one syndrome. The “Other Gram-positives” row includes 
infection with Streptococcus Gp F and other Streptococcus spp. The Other Gram-negatives row includes infection with coliform species, including Enterobacter cloacae, Klebsiella spp, other 
Enterobacter spp, and unspecified Gram-negative organism.
bDiagnostic categorization variables are not mutually exclusive.
cAll Haemophilus influenzae isolates were nontype B.
dAll Salmonella species were identified as nontyphoidal.
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All Gram-positive organisms were sensitive to ceftriaxone. All 
S aureus isolates were methicillin-sensitive.
However, antibiotic resistance was common in Gram-
negative pathogens for standard first-line (39.3% [n = 11 of 28]; 
range, 25%–100%) and second-line (46.4% [n  =  13 of  28]; 
range, 33%–100%) antimicrobials. There was widespread resist-
ance to trimethoprim/sulfamethoxazole in both Gram-positive 
(64.9% [n = 24 of 37]; range, 41%–100%) and Gram-negative 
(81.0% [n  =  17 of  21]; range, 71%–100%) pathogens (see 
Supplementary Table S3).
Factors Associated With Bacteremia and Mortality
A univariable analysis of clinical findings associated with bac-
teremia and mortality (Supplementary Table S1) found that of 
the significant (P < .05) variables, those with highest odds for 
bacteremia were meeting criteria for sepsis (OR, 5.4; 95% con-
fidence interval [CI], 2.8–10.5) and bone infection (OR, 3.5; 
95% CI, 1.5–8.0). The significant variables with highest odds 
for mortality were previous hospitalization (OR, 17.3; 95% CI, 
8.5–35.2), altered consciousness (OR, 12.5; 95% CI, 6.5–24.2), 
and need for oxygen therapy (OR, 5.6; 95% CI, 3.0–10.4).
We used an iterative logistic regression approach to de-
rive a minimal set of variables associated with bacteremia or 
mortality. Male gender, normal hydration status, and normal 
musculoskeletal exams on presentation were significantly less 
prevalent in the bacteremic patients. Sepsis, as defined by the 
international consensus definition [25], was a factor associated 
with bacteremia (see Table 2), whereas there was no association 
of bacteremia with malaria infection.
Mortality was 13.1% (n = 54 of 411) and 10.2% had sequelae 
at time of discharge (n = 42 of 411). The median age (IQR) of 
study participants who died or had sequelae at time of discharge 
was 16.3 (IQR, 5.9–60.0) and 56.0 (IQR, 16.6–111.1) months, 
respectively. Factors associated with mortality as analyzed in 
the multivariable model were a positive history of a comor-
bidity, clinical pallor, presence of tachypnoea, and altered con-
sciousness. Tachycardia was protective against mortality in the 
multivariable logistic regression analysis (Table 2).
DISCUSSION
In this prospective, multicenter study of bacteremia amongst 
study subjects aged 1 month to 18 years presenting with sepsis 
or SFI to 2 hospitals in urban Gambia, we found a high prev-
alence of bacteremia. A  total of 15.8% of all participants had 
an identifiable pathogen on blood culture, higher than that re-
ported in similar studies in SSA [2, 6, 9, 10, 12, 21–23]. A factor 
that may have accounted for this high number was our strict 
inclusion criteria for sepsis and SFI. However, over 84% of par-
ticipants with severe illness had no identifiable pathogen. The 
lack of viral and bacterial molecular diagnostics in this study as 
well as the very high rates of prehospital antibiotic use reported 
by parents, and confirmed by urinary screen for antibiotic 
activity, may therefore have led to an underestimate of the true 
frequency of bacterial etiology in this cohort.
We observed patterns of pathogen prevalence that were 
substantially different from previously published reports, 
highlighting the need for reassessing contemporary bacterial 
epidemiology to guide current and future practice. Combined 
mortality and severe morbidity associated with infection were 
substantial, affecting 23% of patients.
Multivariate analysis identified requirement for antimicro-
bial therapy on admission and requirement for immediate, ag-
gressive management to prevent mortality as clinical features 
that predicted presence of bacteremia. Consistent with other 
recently published studies from SSA, S aureus was the predom-
inant pathogen across all age groups [12, 14, 15, 31–34], except 
in the 2–5 age group where infections with S pneumoniae pre-
dominated. This contrasts with (1) a recent publication from 
Ghana in which nontyphoidal salmonella accounted for more 
than half of all invasive bacterial infections in children under 
5 years of age [13] and (2) a study from The Gambia in 2007 in 
which S pneumoniae was the most common pathogen among 
all age groups [22].
One major factor that is likely to have contributed to this 
change in pathogen prevalence is the introduction of the pneu-
mococcal conjugate vaccine (PCV) to the Gambian Expanded 
Program on Immunisation (EPI), with the 7-valent vaccine 
(PCV7) being introduced in 2009 followed by PCV13 in 2011. 
Recent surveillance studies, completed postintroduction of the 
Gambian PCV program, have shown a substantial reduction in 
invasive pneumococcal disease of approximately 55% among 
children aged 2 to 59  months [32]. Although the Gambian 
EPI is one of the most successful in SSA, with up to 10 vac-
cines being administered and with high vaccine coverage rates, 
it also has a poor record of completing vaccination schedules 
on time [35]. This factor may also have contributed to the high 
morbidity and mortality seen from vaccine-preventable infec-
tions in our cohort. Since the introduction of H influenzae type 
B (Hib) vaccine in The Gambia in 2007, rates of Hib disease 
have decreased, although there has been some recrudescence in 
Eastern Gambia [36]. Of the 6 cases of H influenzae sepsis iden-
tified in this study, none were serotype B.
Antibiotic resistance was found predominantly in Gram-
negative organisms—a recognized and global concern[37]. These 
pathogens were often resistant to the first-line antimicrobials 
and at times resistant to ceftriaxone, which is usually reserved 
for meningitis, severe sepsis, or where other treatment options 
have failed; this may be a reflection on poor antibiotic steward-
ship in The Gambia. Gram-positive organisms were mostly sus-
ceptible to the first-line antimicrobials: crystalline penicillin/
ampicillin and gentamicin. These continue to be the first-line 
antibiotics of choice as set out in the WHO Pocket Book of 
Hospital Care for Children [26], a commonly used resource in 
low-income settings for the clinical diagnosis and management 
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of sick children. Given the increasing predominance of S aureus 
disease in SSA, and our findings that 73% of isolates were pen-
icillin resistant, and 2 of 9 were gentamicin resistant, empiric 
regimens should treat bacteremia caused by S aureus (together 
with S pneumoniae, H influenzae, and E coli) effectively, for in-
stance, using co-amoxiclav, because early adequate treatment of 
sepsis is key for improved survival. Although it was reassuring 
to see that all S aureus isolates were methicillin susceptible, 
close surveillance for emerging resistance remains crucial.
The management of severe sepsis should be guided by blood 
culture and antibiotic sensitivity testing, and this may lead to 
therapeutic options that include broader spectrum antibiotics 
such as piperacillin tazobactam. Maintaining informed choices 
for first- and second-line antibiotic prescribing will require 
ongoing microbiological surveillance and the development of 
antimicrobial stewardship strategies.
Trimethoprim/sulfamethoxazole is commonly used in The 
Gambia because of its broad-spectrum antimicrobial efficacy, 
low cost, and easy availability. However, we found that both 
Gram-negative and -positive bacteria were highly resistant to 
this antibiotic on laboratory testing, suggesting that trimetho-
prim/sulfamethoxazole in The Gambia, and probably elsewhere 
in SSA [38], should be reserved for prophylaxis and treatment 
of Pneumocystis jirovecii pneumonia.
Bacteremia was significantly more common in dehydrated 
children. This finding stresses the importance of assessment 
of hydration status and appropriate fluid resuscitation in sus-
pected sepsis. Soft tissue, joint, and bone infections were asso-
ciated with S aureus, indicating that all such cases need to be 
treated with antistaphylococcal antibiotics.
The risk of mortality was highest in those with comorbidities, 
including sickle cell disease or other congenital conditions, 
and in those with clinical features of pallor, tachypnoea, or 
altered consciousness. Therefore, the presence of these symp-
toms should be considered a “red flag”. They are recognizable by 
nursing and medical staff, and their importance is emphasized 
in the WHO Emergency Triage Assessment and Treatment 
(ETAT) guidelines [39]. Sickle cell disease was tested for in 
patients with anemia and detected in 9 patients. It was not a 
confounder for clinical pallor, because none of these patients 
were classified as having clinical pallor. Although dehydration 
was associated with bacteremia, tachycardia was associated with 
reduced mortality. Tachycardia may reflect hypovolemia caused 
by sepsis rather than dehydration, and it indicates maintained 
hemodynamic compensation. Further studies are needed to 
infer causality in these associations.
This study had strengths and limitations. We found high 
rates of reported prehospital antibiotic usage, confirmed by 
urinary screen for antibiotic activity in a subset of partici-
pants, which has implications for management of patients. 
This could have significantly affected the yield of positive iso-
lates. Bacterial culture positivity rates may have been affected 
by storage of inoculated blood culture bottles at EFSTH before 
processing and the use of suboptimal blood volumes. Children 
up to age 15  years had blood collected in aerobic pediatric 
blood culture bottles, which are optimized for lower blood vol-
umes. The storage and volume of blood are factors known to 
affect both culture yield—particularly for detection of rapidly 
growing bacteria including S pneumoniae—and the likelihood 
of contaminants [40]. Nonetheless, the rate of blood culture 
contamination (5.8% of blood cultures taken) is lower than in 
other SSA studies [12], and it suggests that poor technique is 
unlikely to have greatly influenced our results, reflecting the 
rigorous training undertaken by clinical staff. This study re-
cruited only those children with sepsis or SFI, and thus the 
range of pathogens identified, and the rate of bacteremia, may 
not apply across the range of childhood infection. However, in 
an urban SSA environment where there is widespread and in-
discriminate antibiotic use, this study has enabled us to iden-
tify bacterial pathogens and factors associated with morbidity 
and mortality. We found that antibiotic resistance to first-line 
antibiotics was more common in Gram-negative organisms; al-
though the study focused on community-acquired infections, 
we cannot exclude the possibility that some tertiary referral pa-
tients had nosocomial infections, with a higher risk for resist-
ance. Finally, the relatively small size of this study and number 
of bacterial pathogens identified has meant that we have been 
underpowered to evaluate the role of risk factors such as 
smoking and consanguinity on outcome.
CONCLUSIONS
In conclusion, the bacteremia rate in Gambian pediatric pa-
tients with severe sepsis and SFI was high, despite high rates of 
prehospital antibiotic use. We observed a changing pattern of 
pathogen prevalence and antimicrobial resistance from previ-
ously published data, as well as subregional differences in prev-
alent pathogens. Our study highlights the need for structured 
bacterial surveillance programs in resource-limited settings, 
however scarce the resources may be.
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